NAP

The aim of the project is to investigate pathological sections of glioblastomas - the most common malignant brain tumors with an infauste prognosis1 - with modern machine learning methods and thus to relieve neuropathologists.

According to current research knowledge, the resistance of gliobloastoma to therapy is largely dependent on its strong heterogeneity. However, determination of heterogeneity is a lengthy process that is not part of standard diagnostics. In order to incorporate this step into standard diagnostics, the NAP project is training machine-leaning models that automatically analyze hematoxylin and eosin (HE) stained tissue slides. These HE slides are generated by default in tumor diagnostics, which does not impose any additional burden on clinical staff.

The Institute of Neuropathology at TUM provides the necessary image data for this purpose. The individual image scenes of the pathological sections are each around 6.5 gigabytes in size and have a resolution of 70,000 by 40,000 pixels.


1Glioblastoma multiforme (IDH wt.) (Latin for multiform) is the most common brain malignancy (WHO grade IV) in adults. The median survival is 15 months.

 

Publications

2026
2025
2024
2023

Contact

Daniel Hieber

Phone: 0731/9762-1635

Message Daniel Hieber

Team

Prof. Dr. Johannes Schobel
Daniel Hieber
Maximilian Karthan

PD Dr. Friederike Liesche-Starnecker (UK-Augsburg)

Partners

Institute for Pathology and Molecular Diagnostics - Augsburg University Hospital

Funding

/

 

Duration

Since July 2021

Links

/